Monoclonal Antibody Treatments
The federal government has issued emergency use authorization for monoclonal antibodies. These can be given to high-risk, COVID-positive patients to help reduce the risk of hospitalization and emergency room visits.
These treatments are most effective if given early in the disease process, soon after the onset of COVID-19 symptoms. Because doses are limited, treatments are being managed by the state of Minnesota. See below for information on how to request treatment.
Eligible patients must be:
- COVID positive AND
- Within 8 days from their onset of symptoms AND
- Not hospitalized AND
- Greater than 65 years old OR
- Greater than 55 years old with other comorbidities including chronic kidney disease, diabetes, or other immunosuppressive diseases or treatments OR
- Less than 55 years old with specific comorbidities
This treatment is given through an infusion, and it takes about 2-3 hours.
St. Luke’s offers this treatment through the Minnesota Resource Allocation Platform (MNRAP). MNRAP is an online tool that connects patients and healthcare providers with COVID-19 medications that are in limited supply. The platform also helps to distribute these medications in an equitable way when there is not enough for everyone who needs them.
If you or a loved one may qualify for this treatment, visit the Minnesota Department of Health website for more information and next steps:
- 1.800.657.3504 (Mon. - Fri., 9 am to 4 pm)